Clearside Biomedical, Inc. (CLSD) Operating Lease, Liability USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Clearside Biomedical, Inc. quarterly Operating Lease, Liability history and growth rate from 2019 to 2023.
  • Clearside Biomedical, Inc. Operating Lease, Liability for the quarter ending December 31, 2023 was $1.01 M, a 21.2% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.01 M -$272 K -21.2% Dec 31, 2023 10-K 2024-03-12
Q4 2022 $1.29 M +$610 K +90.4% Dec 31, 2022 10-K 2023-03-14
Q3 2022 $407 K -$351 K -46.3% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $500 K -$338 K -40.3% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $591 K -$325 K -35.5% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $675 K -$314 K -31.7% Dec 31, 2021 10-K 2022-03-11
Q3 2021 $758 K -$301 K -28.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $838 K -$290 K -25.7% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $916 K -$279 K -23.3% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $989 K -$268 K -21.3% Dec 31, 2020 10-K 2021-03-15
Q3 2020 $1.06 M -$385 K -26.7% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $1.13 M -$411 K -26.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.2 M -$434 K -26.6% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $1.26 M Dec 31, 2019 10-K 2020-03-13
Q3 2019 $1.44 M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $1.54 M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.63 M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.